Spinal injury
Data from a post-market clinical study has demonstrated that a force control technology had significant clinical benefits in spinal (thoracolumbar) fusion procedures. Developed by Neo Medical, the company's Force Control Technology was found to offer significant clinical benefit versus legacy surgical approaches, including a 58 per cent reduction in implant related revision surgeries. The study [...]
Researchers have used a stem cell treatment in mouse models of spinal cord injury alongside rehabilitation to restore motor function. The team at Keio University School of Medicine has successfully transplanted human induced pluripotent stem cell-derived neural stem/progenitor cells called hiPSC-NS/PC into the mouse models. They combined the treatment with rehabilitation using progressive-intensity treadmill training [...]
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial. Neurogenic bladder, also called neurogenic lower urinary tract dysfunction, often occurs after a spinal cord injury. The spinal cord helps coordinate bladder storage and voiding. The neurogenic bladder [...]
The Spinal Injuries Association (SIA) has expressed its concern about the recent announcement by Work and Pensions Secretary Liz Kendall regarding significant reforms to disability benefits. The proposed changes, aimed at reducing welfare expenditure by £5 billion annually, include tightening eligibility criteria for Personal Independence Payments (PIP) and overhauling incapacity benefits. The organisation said in [...]
A new study reveals the potential of a promising oral drug candidate, edonerpic maleate, in accelerating recovery and improve motor function in non-human primates after SCI. The researchers used a non-human primate model to investigate the effects of edonerpic maleate on motor recovery following a partial cervical SCI. Initially, the monkeys were trained to retrieve [...]
A new study has revealed the potential of a promising oral drug candidate, edonerpic maleate, in accelerating recovery and improve motor function in non-human primates after spinal cord injury (SCI). The researchers used a non-human primate model to investigate the effects of edonerpic maleate on motor recovery following a partial cervical SCI. Initially, the monkeys [...]
National law firm, Hudgell Solicitors, have renewed their partnership with Spinal Injuries Association (SIA) after a successful year of campaigning for the rights of people with spinal cord injury. Spinal Injuries Association, the expert guiding voice for life after spinal cord injury, and leading law firm Hudgell Solicitors, a firm known for taking on some [...]
NR Times speaks to Spinal Injuries Association (SIA) Chief Executive Officer, Nik Hartley OBE. Winners in the Charity of the Year category at the NR Times Awards 2024, the SIA supports people with spinal cord injury in accessing the right support and navigating the healthcare system so that they can live fulfilled lives. The charity [...]
A clinical trial is set to investigate a treatment for bladder dysfunction, known as neurogenic detrusor overactivity (NDO), in spinal cord injury (SCI) patients - a study that could open the way for clinical development in neuro-urology pathologies affecting millions of patients. The treatment - EG110A - is a genetic medicine which utilises a non-replicating [...]
The growing potential of spinal cord stimulation technology as a treatment for paralysis has been further demonstrated in a UK study. All 10 participants, living with spinal cord injury (SCI), made significant improvements in upper body strength, trunk control and balance. Some of the participants of the Pathfinder2 trial also made gains in hand grip [...]
